Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'18
Mar'17
Mar'16
Mar'15
Mar'14
Mar'13
No of Months
12
12
12
12
12
12
Operating Income
592.00
531.00
465.00
401.00
334.00
297.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
592.00
531.00
465.00
401.00
334.00
297.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
-1.00
Raw Materials Consumed
172.00
159.00
143.00
121.00
106.00
92.00
Power & Fuel Cost
11.00
11.00
10.00
9.00
9.00
10.00
Employee Cost
98.00
87.00
79.00
64.00
52.00
48.00
Operating Expenses
153.00
128.00
121.00
98.00
81.00
67.00
General and Administration Expenses
-1.00
-1.00
17.00
11.00
10.00
8.00
Selling and Distribution Expenses
4.00
3.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
11.00
7.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
463.00
406.00
373.00
306.00
260.00
226.00
Operating Profit (PBDIT) excl Other Income
129.00
124.00
92.00
94.00
73.00
70.00
Other Income
7.00
6.00
7.00
6.00
4.00
2.00
Operating Profit (PBDIT)
136.00
131.00
99.00
101.00
77.00
73.00
Interest
12.00
14.00
16.00
20.00
23.00
27.00
Profit before Depriciation and Tax
123.00
116.00
83.00
80.00
53.00
46.00
Depreciation
34.00
23.00
20.00
21.00
16.00
15.00
Profit Before Taxation & Exceptional Items
89.00
92.00
62.00
59.00
37.00
30.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
89.00
92.00
62.00
59.00
37.00
30.00
Provision for Tax
31.00
32.00
21.00
20.00
13.00
10.00
Profit After Tax
57.00
60.00
40.00
38.00
23.00
20.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
181.00
123.00
86.00
52.00
32.00
15.00
Profit Available for appropriations
239.00
183.00
126.00
91.00
56.00
35.00
Appropriations
239.00
183.00
126.00
91.00
56.00
35.00
Equity Dividend (%)
30.00%
25.00%
25.00%
15.00%
15.00%
15.00%
Earnings Per Share
52.99
54.89
37.12
35.22
21.73
18.67
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 15.65% vs 12.43% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 13.60% vs 12.74% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -2.31% vs -0.81% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 17.00% vs 16.26% in Mar 2025
Compare Profit and Loss Results of Kovai Medical
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
592.00
204.00
388.00
190.20%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
592.00
204.00
388.00
190.20%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
1.00
-1.00
-100.00%
Raw Materials Consumed
172.00
16.00
156.00
975.00%
Power & Fuel Cost
11.00
2.00
9.00
450.00%
Employee Cost
98.00
44.00
54.00
122.73%
Operating Expenses
153.00
6.00
147.00
2,450.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
32.00
-28.00
-87.50%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
11.00
3.00
8.00
266.67%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
463.00
159.00
304.00
191.19%
Operating Profit (PBDIT) excl Other Income
129.00
45.00
84.00
186.67%
Other Income
7.00
2.00
5.00
250.00%
Operating Profit (PBDIT)
136.00
48.00
88.00
183.33%
Interest
12.00
0.00
12.00
0%
Profit before Depriciation and Tax
123.00
47.00
76.00
161.70%
Depreciation
34.00
3.00
31.00
1,033.33%
Profit Before Taxation & Exceptional Items
89.00
44.00
45.00
102.27%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
89.00
44.00
45.00
102.27%
Provision for Tax
31.00
10.00
21.00
210.00%
Profit After Tax
57.00
33.00
24.00
72.73%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
181.00
24.00
157.00
654.17%
Profit Available for appropriations
239.00
58.00
181.00
312.07%
Appropriations
239.00
58.00
181.00
312.07%
Equity Dividend (%)
30%
0%
30.00
Earnings Per Share
52.99
24.84
28.15
113.33%
Profit And Loss - Net Sales
Net Sales 1,585.64 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 15.65% vs 12.43% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 442.37 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.60% vs 12.74% in Mar 2025
Profit And Loss - Interest
Interest 35.53 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.31% vs -0.81% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 244.46 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.00% vs 16.26% in Mar 2025






